← Open Payments lookup

MANUEL CHAVARRIA: Open Payments

NPI 1578614921 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$452 in 23 payments from 9 companies in 2025. Trend: 2023 $338 · 2024 $454 · 2025 $452

Food & beverage: $452
CompanyPaymentsAmount
Lilly USA, LLC8$140
Boehringer Ingelheim Pharmaceuticals, Inc.4$91
Novo Nordisk Inc4$90
AstraZeneca Pharmaceuticals LP2$37
PFIZER INC.1$23
Dexcom, Inc.1$21
SHIELD THERAPEUTICS INC1$19
Organon LLC1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: JARDIANCE, MOUNJARO, Ozempic, PAXLOVID, Dexcom G6 Transmitter, FARXIGA, ACCRUFER, NEXPLANON.

Industry payments across TX — which companies pay providers there.